Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-1117570 in Healthy Adults
NBI-1117570-1769
Phase 1 other active
Quick answer
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-1117570 in Healthy Adults for Neurological and neuropsychiatric conditions is a Phase 1 program (other) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- Neurological and neuropsychiatric conditions
- Phase
- Phase 1
- Modality
- other
- Status
- active